Ryon P. Graf - Fdn Med Inc | 人才画像

基本信息

Career Trajectory

Bio

I am interested in the commercial scaling and clinical evidentiary build of liquid biopsy biomarkers that can improve the treatment and outcomes of patients with cancer. I am fluent in R, data wrangling, and have practical experience in applied clinical biostatistics.

Research Interests

Papers共 226 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Tumor Mutational Burden and Survival on Immune Checkpoint Inhibition in >8000 Patients Across 24 Cancer Types

David R Gandara, Neeraj Agarwal, Shilpa Gupta, Samuel J Klempner,Miles C Andrews,Amit Mahipal, Vivek Subbiah,Ramez N Eskander,David P Carbone, Jonathan W Riess, Sarah Sammons,Jeremy Snider, Lilia Bouzit,Cheryl Cho-Phan, Megan Price,Gerald Li,Julia C F Quintanilha, Richard Sheng Poe Huang,Jeffrey S Ross, David Fabrizio,Geoffrey R Oxnard,Ryon P Graf

Journal for immunotherapy of cancerno. 2 (2025)

Cited0Views0WOSBibtex

A Study of the Homologous Recombination Deficiency Signature (hrdsig) Status of Advanced Esophageal Squamous Cell Carcinoma (AESCC) by Utilizing Comprehensive Genomic Profiling (CGP)

Zakee Mohamed Jiffry,Dean Pavlick,Ethan Sokol,Ryon P Graf,Alexa Betzig Schrock,Gerald Li,Julia Quintanilha,Jerry W. Mitchell,Tamara Jamaspishvili,Jeffrey S. Ross,Alina Basnet

Journal of Clinical Oncologyno. 4_suppl (2025): 485-485

Cited0Views0Bibtex

Clinical Relevance of Tumor Fraction Assessment from Circulating Tumor DNA in Metastatic Colorectal Cancer

Van K. Morris II,Julia Quintanilha,Julia A. Elvin,Ryon P. Graf,Scott Kopetz

JOURNAL OF CLINICAL ONCOLOGYno. 4_SUPPL (2025): 237-237

Cited0Views0Bibtex

Utility of Plasma Circulating DNA Tumor Fraction in Bone-Only Metastatic Breast Cancer: a Real-World Outcomes Study

Gilbert Bader,Julia C F Quintanilha, Deloris Veney,Ryon P Graf, Mia Levy, Lincoln W Pasquina,Daniel G Stover

Breast cancer research and treatment (2025)

Cited0Views0WOSBibtex

Frequency and Impact of a Genome-Wide Homologous Recombination Deficiency Signature (hrdsig Plus ) on the Genomic Landscape of Advanced Colorectal Cancer (CRC)

Faiza Yasin,Dean Pavlick,Ethan Sokol,Ryon P. Graf,Jeffrey S. Ross,Alexa Betzig Schrock,Julia Quintanilha,Gerald Li,Jerry W. Mitchell,Michael Cecchini

JOURNAL OF CLINICAL ONCOLOGYno. 4_SUPPL (2025): 238-238

Cited0Views0Bibtex

Relationship of Circulating Tumor DNA (ctdna) Tumor Fraction with Prognosis in Patients with Metastatic Pancreatobiliary Cancer

Priyadarshini Pathak,Gerald Li,Julia Quintanilha, Rachel B. Keller-Evans,Lincoln W Pasquina, Julia Thierauf,Julia A Elvin,Jeffrey S. Ross,Ryon P Graf,Aparna Raj Parikh,Michael J. Pishvaian

Journal of Clinical Oncology（2025）

Cited0Views0Bibtex

ESR1 mutations (ESR1mut) in HR(+)HER2(-)patients with metastatic breast cancer (MBC): prevalence along treatment course and predictive value for endocrine therapy (ET) resistance in real-world practice

Manali Bhave,Julia Quintanilha,Ryon Graf, Takara Scott,Hanna Tukachinsky,Gerald Li,Alexa Schrock,Geoffrey Oxnard,Mia Levy,Kevin Kalinsky

CANCER RESEARCHno. 9 (2024)

Cited0Views0Bibtex

Prognostic Value of Baseline Circulating Tumor DNA (ctdna) Tumor Fraction (TF) in Metastatic Hormone-Sensitive Prostate Cancer (Mhspc)

Charles B. Nguyen,Irene Tsung,Jessica K. Lee,Lincoln W. Pasquina,Amy Kasputis, Jennie L. Lovett,Ryon P. Graf,Frank Cameron Cackowski,Elisabeth I. Heath,Todd Matthew Morgan,Zachery R. Reichert

Journal of Clinical Oncology（2024）

Cited0Views0Bibtex

Supplementary Figure 4 from Measurement of ctDNA Tumor Fraction Identifies Informative Negative Liquid Biopsy Results and Informs Value of Tissue Confirmation

Christian D. Rolfo,Russell W. Madison,Lincoln W. Pasquina, Derek W. Brown,Yanmei Huang,Jason D. Hughes,Ryon P. Graf,Geoffrey R. Oxnard,Hatim Husain

crossref（2024）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn